Evidence map›Paper›PMID 35474069›Full record

ArticleNature communications2022

Nanocrown electrodes for parallel and robust intracellular recording of cardiomyocytes.

Zeinab Jahed, Yang Yang, Ching-Ting Tsai, Ethan P Foster, Allister F McGuire, Huaxiao Yang, Aofei Liu, Csaba Forro, Zen Yan, Xin Jiang and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Zeinab Jahed *Department of Chemistry and Stanford Wu-Tsai Neuroscience Institute, Stanford University, Stanford, CA, 94305, USA.
Yang Yang *Department of Chemistry and Stanford Wu-Tsai Neuroscience Institute, Stanford University, Stanford, CA, 94305, USA.
Ching-Ting Tsai *Department of Chemistry and Stanford Wu-Tsai Neuroscience Institute, Stanford University, Stanford, CA, 94305, USA.
Ethan P FosterDepartment of Chemistry and Stanford Wu-Tsai Neuroscience Institute, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0002-8228-1875
Allister F McGuireDepartment of Chemistry and Stanford Wu-Tsai Neuroscience Institute, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0001-6388-2934
Huaxiao YangStanford Cardiovascular Institute, Stanford University, Stanford, CA, USA.
Aofei LiuDepartment of Chemistry and Stanford Wu-Tsai Neuroscience Institute, Stanford University, Stanford, CA, 94305, USA.
Csaba ForroDepartment of Chemistry and Stanford Wu-Tsai Neuroscience Institute, Stanford University, Stanford, CA, 94305, USA.
Zen YanCyion Technologies, LLC, Pleasanton, CA, 94566, USA.
Xin JiangCyion Technologies, LLC, Pleasanton, CA, 94566, USA.
Ming-Tao ZhaoStanford Cardiovascular Institute, Stanford University, Stanford, CA, USA.
Wei ZhangDepartment of Chemistry and Stanford Wu-Tsai Neuroscience Institute, Stanford University, Stanford, CA, 94305, USA.
Xiao LiDepartment of Chemistry and Stanford Wu-Tsai Neuroscience Institute, Stanford University, Stanford, CA, 94305, USA.
Thomas LiDepartment of Chemistry and Stanford Wu-Tsai Neuroscience Institute, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0002-8656-0679
Annalisa PawloskyGoogle Accelerated Sciences, Google LLC, Mountain View, 94043, CA, USA.ORCID 0000-0003-3408-986X
Joseph C WuStanford Cardiovascular Institute, Stanford University, Stanford, CA, USA.ORCID 0000-0002-6068-8041
Bianxiao CuiDepartment of Chemistry and Stanford Wu-Tsai Neuroscience Institute, Stanford University, Stanford, CA, 94305, USA. Bcui@stanford.edu.ORCID 0000-0002-8044-5629

Funding

Single Cell Sequencing of Human iPSC-CM Subtype Identity and FunctionR01HL145676 · NHLBI · STANFORD UNIVERSITY · PI MARK MERCOLA, Joseph C. Wu · 2019 to 2026
$5.1M
Elucidating Anthracycline-Induced Cell Type-Specific Cardiovascular Toxicity with CRISPRi/a ScreensR01HL150693 · NHLBI · STANFORD UNIVERSITY · PI Ronglih Liao, Joseph C. Wu · 2021 to 2026
$4.1M
Nanoscale probes for sensing molecular functions in live cellsR35GM141598 · NIGMS · STANFORD UNIVERSITY · PI CUI, BIANXIAO · 2021 to 2025
$3.4M
An integrated human stem cell model for elucidating NOTCH signaling in myocardial-endocardial interactions in cardiac development and diseaseR01HL155282 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI Mingtao Zhao · 2021 to 2026
$3.2M
An electrophysiology platform that enables robust, scalable and long-term intracellular recording of cardiomyocytesR01HL165491 · NHLBI · STANFORD UNIVERSITY · PI CUI, BIANXIAO · 2022 to 2025
$2.2M
Label-free Optical Recording of Neuroelectric ActivitiesR01NS121934 · NINDS · STANFORD UNIVERSITY · PI CUI, BIANXIAO, MUELLER, HOLGER · 2021 to 2025
$2.2M
Effect of Microgravity on Drug Responses Using Engineered Heart TissuesUH3TR002588 · NCATS · STANFORD UNIVERSITY · PI PRUITT, BETH L, WU, JOSEPH C. · 2020 to 2022
$1.6M
Developing nanoscale electrophysiology sensors for robust intracellular recordingR01GM125737 · NIGMS · STANFORD UNIVERSITY · PI CUI, BIANXIAO · 2017 to 2020
$1.4M
NCATS NIH HHS UH3 TR002588NHLBI NIH HHS R01 HL145676NHLBI NIH HHS R01 HL150693NHLBI NIH HHS R01 HL155282NHLBI NIH HHS R01 HL165491NIGMS NIH HHS R01 GM125737NIGMS NIH HHS R35 GM141598NINDS NIH HHS R01 NS121934
6 · The paper itself

Abstract

Drug-induced cardiotoxicity arises primarily when a compound alters the electrophysiological properties of cardiomyocytes. Features of intracellular action potentials (iAPs) are powerful biomarkers that predict proarrhythmic risks. In the last decade, a number of vertical nanoelectrodes have been demonstrated to achieve parallel and minimally-invasive iAP recordings. However, the large variability in success rate and signal strength have hindered nanoelectrodes from being broadly adopted for proarrhythmia drug assessment. In this work, we develop vertically-aligned nanocrown electrodes that are mechanically robust and achieve > 99% success rates in obtaining intracellular access through electroporation. We validate the accuracy of nanocrown electrode recordings by simultaneous patch clamp recording from the same cell. Finally, we demonstrate that nanocrown electrodes enable prolonged iAP recording for continual monitoring of the same cells upon the sequential addition of four incremental drug doses. Our technology development provides an advancement towards establishing an iAP screening assay for preclinical evaluation of drug-induced arrhythmogenicity.

Indexed as

Electrophysiological PhenomenaMyocytes, CardiacAction PotentialsElectrodesElectroporation

Identifiers

PMID35474069
PMCPMC9042818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.